Hypertension Trial, Recruiting NCT05183763 Sponsor: Tulane University Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT05183763
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are fully insured by Blue Cross Blue Shield of Louisiana (BCBSLA)
  • People who have been continuously enrolled with BCBSLA for at least one year
  • People who plan to remain a BCBSLA member for the next year
  • People who speak English
  • People who have access to a telephone
  • People aged 40 years or older
  • People who have been diagnosed with essential high blood pressure (the most common form of high blood pressure)
  • People who are currently filling a prescription for blood pressure-lowering medication
  • People whose blood pressure medication refill history suggests they are not picking up their medication consistently enough (confirm with trial site for exact measurement)
  • People whose self-reported answers to a medication-taking questionnaire suggest they sometimes miss doses (confirm with trial site for exact measurement)
  • People whose blood pressure is not currently well controlled (a top number of 130 or higher, or a bottom number of 80 or higher)
  • People who want to improve their blood pressure

Who may not be able to join:

  • People who live in the same household as someone already enrolled in this study
  • People who are currently enrolled in another clinical trial focused on medication-taking or blood pressure control
  • People with moderate to severe memory or thinking difficulties

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marie A Krousel-Wood, MD, MSPH, Tulane University

Phone: 504-988-1075

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tulane University
Registry
ClinicalTrials.gov
Start date
7 March 2022
Est. completion
30 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Difference in proportion with PDC >=0.8 at 12 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov